Literature DB >> 19912302

A model of treatment decision making when patients have advanced cancer: how do cancer treatment doctors and nurses contribute to the process?

L McCullough1, E McKinlay, C Barthow, C Moss, D Wise.   

Abstract

This qualitative study describes how doctors and nurses report their contribution to treatment decision-making processes when patients have advanced cancer. Thirteen nurses and eight doctors involved in cancer treatment and palliation in one geographical location in New Zealand participated in the study. Data were collected using qualitative in-depth, face-to-face interviews. Content analysis revealed a complex context of decision making influenced by doctors and nurses as well as the patient and other factors. A model of clinician and patient decision making emerged with a distinct and cyclical process as advanced cancer remits and progresses. When patients have advanced cancer, nurses and doctors describe a predictable model of decision making in which they both contribute and that cycles through short- and long-term remissions; often nowadays to the point of the patient dying. In conclusion, the findings suggest doctors and nurses have different but complementary roles in what, when and how treatment choices are negotiated with patients, nevertheless within a distinct model of decision making.

Entities:  

Mesh:

Year:  2009        PMID: 19912302     DOI: 10.1111/j.1365-2354.2009.01074.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  "Well, I think there is great variation...": a qualitative study of oncologists' experiences and views regarding medical criteria and other factors relevant to treatment decisions in advanced cancer.

Authors:  Jan Schildmann; Jacinta Tan; Sabine Salloch; Jochen Vollmann
Journal:  Oncologist       Date:  2013-01-03

2.  Patients' experiences of the decision-making process for clinical trial participation.

Authors:  Trine A Gregersen; Regner Birkelund; Maiken Wolderslund; Karina Dahl Steffensen; Jette Ammentorp
Journal:  Nurs Health Sci       Date:  2022-03-21       Impact factor: 2.214

Review 3.  Feasibility and effectiveness of tools that support communication and decision making in life-prolonging treatments for patients in hospital: a systematic review.

Authors:  Maureen Thodé; H Roeline W Pasman; Liesbeth M van Vliet; Olga C Damman; Johannes C F Ket; Anneke L Francke; Irene P Jongerden
Journal:  BMJ Support Palliat Care       Date:  2020-10-05       Impact factor: 4.633

Review 4.  Nurses' perspective on their involvement in decision-making about life-prolonging treatments: A quantitative survey study.

Authors:  Susanne A M Arends; Maureen Thodé; Anke J E De Veer; H Roeline W Pasman; Anneke L Francke; Irene P Jongerden
Journal:  J Adv Nurs       Date:  2022-03-21       Impact factor: 3.057

Review 5.  Withdrawal of anticancer therapy in advanced disease: a systematic literature review.

Authors:  G Clarke; S Johnston; P Corrie; I Kuhn; S Barclay
Journal:  BMC Cancer       Date:  2015-11-11       Impact factor: 4.430

6.  Chemotherapy Use at the End of Life in Uganda.

Authors:  Daniel Low; Emily C Merkel; Manoj Menon; Gary H Lyman; Henry Ddungu; Elizabeth Namukwaya; Mhoira Leng; Corey Casper
Journal:  J Glob Oncol       Date:  2017-01-18

7.  The role of hospital nurses in shared decision-making about life-prolonging treatment: A qualitative interview study.

Authors:  Danique W Bos-van den Hoek; Maureen Thodé; Irene P Jongerden; Hanneke W M Van Laarhoven; Ellen M A Smets; Dorien Tange; Inge Henselmans; H Roeline Pasman
Journal:  J Adv Nurs       Date:  2020-10-20       Impact factor: 3.057

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.